Assembly Biosciences Reports Positive Topline Results from Phase 1b Clinical Trial of Next-Generation Investigational Capsid Assembly Modulator ABI-4334 in Chronic Hepatitis B

Related posts

• The Foundation for Sarcoidosis Research Awards $450,000 to Support Early-Career Investigators Through the 2025 Fellowship Grant

  July 14, 2025 GlobeNewswire 0

  The Foundation for Sarcoidosis Research Awards $450,000 to Support Early-Career Investigators Through the 2025 Fellowship Grant

  Source: Medical

  Medical 

• [Latest] Global Magnesium Supplements Market Size/Share Worth USD 8.94 Billion by 2034 at a 7.43% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

  July 9, 2025 GlobeNewswire 0

  [Latest] Global Magnesium Supplements Market Size/Share Worth USD 8.94 Billion by 2034 at a 7.43% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

  Source: Medical

  Medical 

• RTI and Kinova Partner to Integrate Intelligent Connectivity into Medical Robotics

  July 8, 2025 GlobeNewswire 0

  RTI and Kinova Partner to Integrate Intelligent Connectivity into Medical Robotics

  Source: Medical

  Medical